care2trans SRL
care2trans reported total assets of 817,653 € at the end of the 2025 financial year (annual accounts filed with the NBB on 02 Jul 2026).
The score of care2trans shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +49 % Total assets +27 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
care2trans's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 169,332 € | ||||
| Equity | 797,391 € | ||||
| Cash | 232,500 € | ||||
| EBITDA | 253,544 € | ||||
| Total assets | 817,653 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 02 Jul 2026
- Year ended 31 Dec 2024filed on 26 Jun 2025
- Year ended 31 Dec 2023filed on 09 Jul 2024
- Year ended 31 Dec 2022filed on 20 Jul 2023
- Year ended 31 Dec 2021filed on 23 Aug 2022
care2trans's financial analysis
- Solvency97.5%sector median: 60.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of care2trans
care2trans's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0669.887.344
- VAT number
- BE0669887344
- Peppol
- Registered · 0208:0669887344 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 23 Jan 2017
- Registered office
- 9820 Merelbeke-Melle
- Latest accounts
- 2025 · filed on 02 Jul 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
care2trans (SRL) has been based in Merelbeke-Melle since 2017, active in: research and experimental development on biotechnology. For 2025, it reports a net profit of 169,332 € and equity of 797,391 €; its revenue is not published. Its solvency stands at 97.5%, above the median of its sector (60.4%).
Companies similar to care2trans
Companies in the same business, of comparable size and area, outside its group.
- Lavima fertility Research and experimental development on natural sciences and engineering Aalst · balance sheet 863,324 €
- Cell-Cell BIO Research and experimental development on natural sciences and engineering Ghent · balance sheet 990,571 €
- Pathosense Research and experimental development on natural sciences and engineering Lier · balance sheet €1.21m
- InnoSer België Research and experimental development on natural sciences and engineering Diepenbeek · balance sheet €2.12m
- Spectralys Biotech Research and experimental development on natural sciences and engineering Charleroi · balance sheet 444,695 €
- Radiologie DRS.VAN Meerbeeck Other education n.e.c. Bornem · balance sheet 843,721 €
- Apr. Biol. Inger Brandt Research and experimental development on natural sciences and engineering Lebbeke · balance sheet €2.44m
- CTTec Research and experimental development on natural sciences and engineering Menen · balance sheet 259,750 €
Frequently asked questions about care2trans
What is the revenue of care2trans?
care2trans files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of care2trans?
In Belgium, the VAT number is the company number prefixed with BE: BE0669887344 for care2trans, if the company is VAT-registered. Its company number (CBE) is 0669.887.344.
Where is the registered office of care2trans?
According to the CBE register, the registered office of care2trans is in 9820 Merelbeke-Melle.
What is the equity of care2trans?
At the close of the 2025 financial year, the equity of care2trans amounts to 797,391 €, a solvency of 97.5% of total assets.
Who manages care2trans?
The register lists 1 active mandates at care2trans. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of care2trans
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →